SlideShare a Scribd company logo
1 of 53
MOOD
DISORDER
DEPRESSIVE
DISORDER
OBJECTI
VES
At the end of lecture students should be able to:
• Explain Depressive Mood disorders and its
various types as given in DSM V
classification.
• Describe prevalence; etiology; risk factors and
D/D of Depressive disorder.
• Formulate a management plan of depressive
disorder based on BIOPSYCHOSOCIAL
MODEL.
CASE:
A 42-year-old man comes to his outpatient psychiatrist with
complaints of a depressed mood, which he states is identical to
depressions he has experienced previously.
He was diagnosed with major depression for the first time 20
years ago. At that time, he was treated with imipramine, up to 150
mg/d, with good results. During a second episode, which
occurred 15 years ago, he was treated with imipramine, and once
again his symptoms remitted after 4 to 6 weeks. He denies illicit
drug use or any recent traumatic events. The man states that
although he is sure he is experiencing another major depression,
he would like to avoid imipramine this time because it produced
unacceptable side effects such as dry mouth, dry eyes and
constipation.
•
CAS
E
➤What is the psychiatric symptoms and sign in this
case?
➤ What is the best therapy?
➤ What are the side effects of the proposed
therapy?
MOOD
DISORDER
• Previously called “affective disorders.”
• The term “mood disorders is preferred today.
• “Mood disorders” refers to disturbance in sustained
emotional states rather than external expression of the
present emotional state’
• A persons emotional state or outlook at particular
time or Generalized state of feeling.
Different type of
Mood
• Normal
mood:
Low mood experienced
by healthy people
• Grief
:
• Adjustment
:
Anxiety and depressive
features because of losses
Few mood features
because of life events within
6 months of event
• Depressive
disorder
Classification of Depressive
Disorder
• Disruptive Mood Dysregulation Disorder
• Major Depressive Disorder
• Persistent Depressive Disorder
(Dysthymia)
• Premenstrual Dysphoric Disorder
• Substance/Medication-Induced
Depressive Disorder
• Depressive Disorder Due to Another
Medical Condition
• Other Specified Depressive Disorder
• Unspecified Depressive Disorder
DSM V Diagnostic
criteria's
A. Five (or more) symptoms for 2-week period and
represent a
change from previous with impaired functioning;
• At least one of the core symptoms is either
1
.
2
.
Depressed mood
Loss of interest or
pleasure.
Associated
symptoms
3
.
4
.
5
.
Significant weight loss when not dieting or weight
gain
children, consider failure to make expected weight
gain.)
Insomnia or hypersomnia nearly every day.
Psychomotor agitation or retardation nearly every
6. Fatigue or loss of energy nearly
every day.
7. Feelings of worthlessness or excessive or
inappropriate guilt (which may be delusional) nearly every
day (not merely self reproach or guilt about being sick).
8. Diminished ability to think or concentrate, or indecisiveness
9. Recurrent thoughts of death (not just fear of dying), recurrent
suicidal ideation without a specific plan, or a suicide
attempt or a specific plan for committing suicide.
B. The symptoms cause clinically significant distress or
impairment in social, occupational, or other important areas of
functioning.
C
.
The episode is not attributable to the physiological
effects of a substance or to another medical condition.
Dysthymic disorder
• A depressive disorder less severe than major depressive disorder
• Chronic depressive symptoms, which are not severe enough to fit
the diagnosis of major depressive episode
• Lasted at least 2 years
Atypical depression
Younger age of onset
More frequent, coexisting with panic disorder, substance-related
problems, and somatic symptoms features
•Mood reactivity (as compared to usual depression’s lack of response
to positive events)
• Overeating
• Oversleeping
• Leaden paralysis
• Sensitivity to interpersonal rejection
Minor Mood Disorder
Two-thirds of the psychiatric disorders seen in general practice.
The most frequent symptoms are:
● Anxiety and worrying thoughts
● Sadness and depressive thoughts
● Irritability
● Poor concentration
● Insomnia
● Fatigue
● Somatic symptoms
● Excessive concern about bodily function.
 Half of patients with minor mood disorder improve within 3
months
 ¼ in 6 months.
Moderate depressive disorder
• In depressive disorders of moderate
severity the central features are again low
mood, lack of enjoyment, reduced energy,
and pessimistic thinking
• 2 core features and 3 associated
features.
Severe depressive
disorder
• All features occurs with greater intensity
• Worthlessness, hopelessness, guilt, ill health OR poverty of
thought.
• Delusions and hallucinations mood-congruent
• A patient with a delusion of impoverishment may wrongly believe
that he has lost all his money in a business venture.
• A patient with nihilistic delusions may believe that he has no future,
or that some part of him has ceased to exist or function (e.g. that his
bowels are wholly blocked—sometimes called Cotard’s
syndrome).
walking corpse syndrome
MS
E
Appearance
• The patient’s appearance is often
characteristic Psychomotor retardation.
• Agitation and feeling of restlessness which may
manifest
Mood
• The low mood, diurnal variation of mood
• Anxiety and irritability are frequent.
• Lack of interest and loss of enjoyment (anhedonia)
• no spontaneously.
• No enthusiasm for activities and hobbies that they
would normally enjoy, and describe a loss of zest for
living and for the pleasure from everyday things.
MS
E
• Depressive thinking
• Pessimistic thinking (‘depressive cognitions’).
• Thoughts concerned with the present.
• Thoughts concerned with the future.
• Thoughts concerned with the past.
• Depersonalization, obsessional symptoms,
• phobias, and conversion symptoms such as
loss of
function of a limb
DIFFERENTIAL
DIAGNOSIS
• Normal sadness
• Grief.
• Bipolar disorder.
• Anxiety disorder.
• Functional physical
symptoms.
• Schizophrenia.
• Dementia.
• Substance abuse.
Prevalence
• Lifetime risk of depressive disorder is around 20% in
both
developed and developing countries
• women than in men: the sex ratio is about 2 to 1.
• Primary care (up to 40% of attenders)
• More common in urban than rural populations
• Depressive disorders cause both direct and indirect
costs to
health services.
• Depression may be undetected, especially when
there are accompanying physical symptoms.
• Unrecognized depressive disorder may slow recovery
and
worsen prognosis in physical illness.
ETIOLO
GY
Genetic
causes
• Parents, siblings, and children of severely depressed
patients have a higher lifetime risk for mood disorder
(10– 15%) than the general population (1–2%).
• Twin studies of adopted children shows increased risk
of developing the disorder in a child who was born to a
parent with a history of serious depressive disorder.
PREDISPOSING ENVIRONMENTAL
FACTORS
• Prolonged diversity of difficulties in marriage or at
work.
• Adverse circumstances seem to prepare the ground for a
final
acute stressor, which precipitates the disorder.
(Example: several young children, poor economic
circumstances, and an unsupportive marriage increase
vulnerability to depression).
• People whoare more vulnerable include:
– Lack of confiding relationships
– Unemployment
PRECIPITATING ENVIRONMENTAL
FACTORS
• Depressive disorder follow stressful life events.
• The effect is substantial; the risk of developing a
depressive disorder is increased about six fold in the 6
months after experiencing moderately severe life
events
Physical conditions as
predisposing or
precipitating factors
• Most physical conditions are non-specific stressors but a few
appear to precipitate depressive disorder by direct biological
mechanisms. They include:
• Influenza and some other viral infections/ other infection(AIDS)
• Anemia
• Childbirth
• Parkinson’s disease.
• Metabolic syndromes
• Endocrine abnormalities
• Heart diseases
• Epilepsy
• Cancers
• Substance abuse
• Nutritional deficiencies
• Neurological disorders
Psychological mediating
processes.
• Two kinds of complementary mediating processes
have
• been studied:
– psychological and biochemical.
1 Abnormalities of emotional processing
2 Tendency to remember unhappy events more easily than happy
ones.
4 Cognitive distortions.
5 Illogical ways of thinking allow the intrusive gloomy thoughts
and the unrealistic expectations to persist despite evidence to
the contrary.
Biochemical mediating
processes.
1
2
3
• Strongest evidence is for an abnormality of 5-HT (serotonin) function.
• There are three main strands of evidence.
Concentrations of the main 5-HT metabolite (5-HIAA) are
reduced in the cerebrospinal fluid (CSF)
5-HT concentrations are reduced in the brains of depressed be
caused by drugs used to commit suicide or by post-mortem
changes.
Neuroendocrine functions that involve 5-HT
transmission are reduced in depressed patients.
4 Tryptophan (amino acid precursor of 5-HT) depletion via diet can
lead to
increased depressive mood in people who have recovered.
5 Noradrenergic (NA) function also seems to be reduced in
depressive disorders.
MEDICAL CAUSES OF DEPRESSION:
• Pharmacologic: steroids, methyldopa, cimetidine, reserpine,
cyclosporine, amphetamine withdrawal.
• Infectious diseases: Influenza, viral hepatitis, IMN, T.B.
• Endocrinal: Hypothyroidism, Cushing, Addison's,
postpartum, D.M.
• Collagen: SLE, rheumatoid.
• Neurological: parkinsonism, stroke, multiple sclerosis.
• Nutritional: Vit B12, Vit C &D , Folate, Niacin deficiency,
hypercalcemia
• Neoplastic: Cancer head pancreas, disseminated malignancy
Endocrine Abnormalities
• Cushing’s syndrome
• Addison’s disease
• Hyperparathyroidism
• hypothyroidism
• childbirth/ menopause /premenstrual syndrome
• Plasma cortisol is increased in about half of patients
with depressive disorder.
• Elevation of cortisol can occur after a prolonged life
stress may predispose to depression by interfering with
brain 5-HT function.
Depression: Differences in Women Compared with Men
Parameters Differences in women compared
with men
Lifetime prevalence rate 20 percent (10 percent in men)
Age of onset May be earlier
Duration of episodes May be longer
Course of illness May more often be recurrent
Seasonal effect on mood Greater
Association with stressful life events More frequent
Atypical symptoms of depression (e.g.,
hypersomnia, hyperphagia
Experienced more often
Severity of depression May be greater if self-rated by the
patient
Guilt feelings May be experienced more often
Suicidal behavior Suicide attempted more often but
much less often successfully
Association of anxiety disorders,
especially panic and phobic symptoms
Greater
Association of eating disorders Greater
Association of alcoholism and
substance use disorder
Usually less
Association of thyroid disease Greater
Association of migraine headaches Greater
Association of antisocial, narcissistic
and obsessive-compulsive
personalities
Less
Effect of exogenous and endogenous
gonadal steroids on mood
Greater
Prognosis
• Two-thirds of those who are depressed never
seek treatment and suffer needlessly.
• 80%-90% of those who seek treatment for
depression can feel better within just a few
weeks.
Prognosis
• 80% of the patients with major depression
will experience further episode of depression.
• Average length of each episode is 6 months.
• 25 years follow up shows that on average
patients experience 5 further episodes.
• 1/3 patients do not receive full remission.
“To acquire knowledge, one must study,
but to acquire wisdom one must observe.”
Bio Psycho
Social
Management
Investigatio
n
• Detection of depression can be improved if the
doctor always remembers to ask two simple
screening questions:
1 During the last month, have you often been
bothered by feelingdown, depressed, or
hopeless?
2 During the last month, have you often been bothered
by
little interest or pleasure in doing things?
• Diagnosis depends on thorough history taking and
examination of the physical and mental state.
Investigatio
n
Diagnosis
● History
● Mental state
● Relevant physical
examination
● Relevant physical
investigation
● Informants’ accounts
Severity
● Biological symptoms
● Psychotic symptoms
● Suicide risk, risk to others
● Effect on social functioning
Aetiology
● Psychological
● Social
● Physical illness
● Drug therapy
Social
consequences
● Patient’s everyday
life
● Partner and family
● Dangers at work
Social resources
● Family support
● Housing
● Work
Treatment
options
1 Make diagnosis and assess
severity
2 Assess need for hospital treatment or
multidisciplinary team involvement
3 Explain diagnosis, treatment plan, and likely
effect of
treatment (benefits and harms) to patient and
relatives
4 Review after 7 days , Assess side effects, provide
explanation
and reassurance and Monitor every 7–14 days
5 Assess response to treatment by 6 weeks
If better: Continue treatment ,Review need to
Classification of
Medication
• SSRI
fluoxetine
paroxetin
e
sertralin
e
citalopram and
escitalopram
• SNRI
– Venlaflexine
– Duloxieten
• TRICYCLIC
– Imipramine
– Amitriptyline
– Dothiapine
– clomipramine
• MAOI
Indications for SSRI treatment for
depressive
disorder
• Concomitant cardiac disease
• Intolerance to anticholinergic side
effects
• Significant risk of deliberate overdose
• Excessive weight gain with previous
tricyclic treatment
• Sedation undesirable
• Obsessive-compulsive disorder with
depression
Side effects of
SSRI
• Gastrointestinal Nausea
• Flatulence
• Diarrhea
• Insomnia
• Restlessness
• Irritability
• Agitation
• Tremor
• Headache
• Acute dystonia, rarely
• Erectile andEjaculatory
delay
Tricyclic
antidepressants
• Toxic effects on the cardiovascular system.
• Tricyclic's have been replaced for most purposes by
SSRIs.
• Proven effectiveness in severely depressed patients.
Contraindications
• Agranulocytosis
• Liver damage
• Glaucoma
• Prostatic hypertrophy
• Used cautiously in epileptic
patients.
Side effects of Tricyclic
Antidepressants
Anticholinergic effects :
• Dry mouth, Constipation, Impaired visual accommodation
• Difficulty in micturition, Worsening of glaucoma, Confusion
(especially in
the elderly)
Alpha- adenoreceptor blocking effects
• Drowsiness
• Postural hypotension
• Sexual dysfunction
Cardiovascular effects
• Tachycardia
• Hypotension
• Cardiac conduction deficits
• Cardiac arrhythmia
Other effects Seizures
Weight gain
Psychological
Treatment
• Support, encouragement, and repeated explanation
that
they are suffering from illness, not moral failure.
• When the depressive disorder appears to have
been precipitated by life problems, discussion and
problem- solving counselling may be required.
• CBT
• When the depressive disorder is severe,
discussion of problems may increase
hopelessness.
• When mood improves, the problems can be
reconsidered.
Social
Intervention
• Family support
• Family education and involvement in
care
• Financial support
• Relaxation in work
Indications for ECT
1 The need for an urgent response:
(i) when life is threatened in a severe depressive disorder
• Refusal to drink or eat
• Intense suicidal ideation
(ii) Puerperal psychiatric disorders when it is important that the
mother should resume the care of her baby
2
3
Resistant depressive disorder
Failure to thorough treatment with antidepressant
medication.
Two uncommon syndromes
(i) Catatonic
schizophrenia
(ii) Depressive stupor
THE ANSWER OF THE CASE (1)
•
• Summary: A 42-year-old man complains of
symptoms of major depression identical to two
prior episodes he experienced in the past.
Previously, he was successfully treated with a
tricyclic antidepressant (TCA), although this class
of medication often produces anticholinergic side
effects such as dry mouth, dry eyes, and
constipation, of which this patient complains. The
question becomes what medication should be used
to treat recurrent major depression when tricyclics
are not an option.
•
Best therapy:
• A selective serotonin reuptake inhibitor (SSRI) such as sertraline, paroxetine,
citalopram, fluoxetine, or fluvoxamine is one of the first-line choices of
medication for this patient.
• Selective serotonin norepinephrine reuptakeinhibitors (SSNRI) such as
venlafaxine and duloxetine are also first-line treatment options.
Thank
you

More Related Content

Similar to depression 1 (1).pptx dnsjsjxkskskskskjdjdd

Depression among medical students
Depression among medical studentsDepression among medical students
Depression among medical students
Sidra Muntaha
 
Snack N Yak 1 - Mood Disorders Handout
Snack N Yak 1 - Mood Disorders HandoutSnack N Yak 1 - Mood Disorders Handout
Snack N Yak 1 - Mood Disorders Handout
Sarah Rach
 
Adjustment and mood disorders
Adjustment and mood disordersAdjustment and mood disorders
Adjustment and mood disorders
Hala Sayyah
 

Similar to depression 1 (1).pptx dnsjsjxkskskskskjdjdd (20)

Mood disorders
Mood disordersMood disorders
Mood disorders
 
mood disorder.pptx
mood disorder.pptxmood disorder.pptx
mood disorder.pptx
 
Mood disorders slide
Mood disorders slideMood disorders slide
Mood disorders slide
 
PsychologicalDisorders to create lcelh local lan
PsychologicalDisorders to create lcelh local lanPsychologicalDisorders to create lcelh local lan
PsychologicalDisorders to create lcelh local lan
 
Mental disorder and treatment.pptx
Mental disorder and treatment.pptxMental disorder and treatment.pptx
Mental disorder and treatment.pptx
 
Depression among medical students
Depression among medical studentsDepression among medical students
Depression among medical students
 
Depression
DepressionDepression
Depression
 
Depression pptttt
Depression ppttttDepression pptttt
Depression pptttt
 
Major depressive disorders
Major depressive disordersMajor depressive disorders
Major depressive disorders
 
Mood disorder and depression
Mood disorder and depressionMood disorder and depression
Mood disorder and depression
 
MOOD.pptx
MOOD.pptxMOOD.pptx
MOOD.pptx
 
Snack N Yak 1 - Mood Disorders Handout
Snack N Yak 1 - Mood Disorders HandoutSnack N Yak 1 - Mood Disorders Handout
Snack N Yak 1 - Mood Disorders Handout
 
Major depressive disorder
Major depressive disorderMajor depressive disorder
Major depressive disorder
 
Adjustment and mood disorders
Adjustment and mood disordersAdjustment and mood disorders
Adjustment and mood disorders
 
mooddisorders-170721030958 (1).pptx
mooddisorders-170721030958 (1).pptxmooddisorders-170721030958 (1).pptx
mooddisorders-170721030958 (1).pptx
 
MOOD DISORDERS
MOOD DISORDERSMOOD DISORDERS
MOOD DISORDERS
 
Depression facts
Depression factsDepression facts
Depression facts
 
Mood disorders
Mood disorders Mood disorders
Mood disorders
 
A review on screening models of anti-depressant drugs
A review on screening models of anti-depressant drugsA review on screening models of anti-depressant drugs
A review on screening models of anti-depressant drugs
 
Mood disorder dr.saman
Mood disorder dr.samanMood disorder dr.saman
Mood disorder dr.saman
 

More from epicsoundever

Abdomen and Pelvis Clinicals (1).pdfvmvnxcxc
Abdomen and Pelvis Clinicals (1).pdfvmvnxcxcAbdomen and Pelvis Clinicals (1).pdfvmvnxcxc
Abdomen and Pelvis Clinicals (1).pdfvmvnxcxc
epicsoundever
 
Bones upper limb.pdf ckvncxkvnxcvnxcknxcknxk
Bones upper limb.pdf ckvncxkvnxcvnxcknxcknxkBones upper limb.pdf ckvncxkvnxcvnxcknxcknxk
Bones upper limb.pdf ckvncxkvnxcvnxcknxcknxk
epicsoundever
 
MULTIPLE_SCLEROSIS_ (1).pptx trrhggfrffghhv
MULTIPLE_SCLEROSIS_ (1).pptx trrhggfrffghhvMULTIPLE_SCLEROSIS_ (1).pptx trrhggfrffghhv
MULTIPLE_SCLEROSIS_ (1).pptx trrhggfrffghhv
epicsoundever
 
anatomy and physiology of cornea-.pdf gfhh
anatomy and physiology of cornea-.pdf gfhhanatomy and physiology of cornea-.pdf gfhh
anatomy and physiology of cornea-.pdf gfhh
epicsoundever
 
Lecture 16 - Dementia.ppt bvvbbnngfcvbhhhh
Lecture 16 - Dementia.ppt bvvbbnngfcvbhhhhLecture 16 - Dementia.ppt bvvbbnngfcvbhhhh
Lecture 16 - Dementia.ppt bvvbbnngfcvbhhhh
epicsoundever
 
SEADTIVE HYPNOTIC DRUGS PPT 2.pdf hghhhhhh we
SEADTIVE HYPNOTIC DRUGS  PPT 2.pdf hghhhhhh weSEADTIVE HYPNOTIC DRUGS  PPT 2.pdf hghhhhhh we
SEADTIVE HYPNOTIC DRUGS PPT 2.pdf hghhhhhh we
epicsoundever
 
liver injury.pptx jhfvbghhbbnnnnbcdddvhhhhh
liver injury.pptx jhfvbghhbbnnnnbcdddvhhhhhliver injury.pptx jhfvbghhbbnnnnbcdddvhhhhh
liver injury.pptx jhfvbghhbbnnnnbcdddvhhhhh
epicsoundever
 
DEMOGRAPHY.ppt hfggghfssxdrhjjjhddfhhjhgv
DEMOGRAPHY.ppt hfggghfssxdrhjjjhddfhhjhgvDEMOGRAPHY.ppt hfggghfssxdrhjjjhddfhhjhgv
DEMOGRAPHY.ppt hfggghfssxdrhjjjhddfhhjhgv
epicsoundever
 
LOCAL ANESTHETICS 2024.pdf jdhsjsnsnejsjnsjwns
LOCAL ANESTHETICS 2024.pdf jdhsjsnsnejsjnsjwnsLOCAL ANESTHETICS 2024.pdf jdhsjsnsnejsjnsjwns
LOCAL ANESTHETICS 2024.pdf jdhsjsnsnejsjnsjwns
epicsoundever
 
Ataxia.pptx dbdhndjsjsjdkjzjxjdbfbxnzndndnxj
Ataxia.pptx dbdhndjsjsjdkjzjxjdbfbxnzndndnxjAtaxia.pptx dbdhndjsjsjdkjzjxjdbfbxnzndndnxj
Ataxia.pptx dbdhndjsjsjdkjzjxjdbfbxnzndndnxj
epicsoundever
 
Liver injury-2.pptx bxjdndannsmxmfmsmmssmzmzm
Liver injury-2.pptx bxjdndannsmxmfmsmmssmzmzmLiver injury-2.pptx bxjdndannsmxmfmsmmssmzmzm
Liver injury-2.pptx bxjdndannsmxmfmsmmssmzmzm
epicsoundever
 
Spine Trauma.pptx hgfhjddxxddghhuhbfdvhhjbff
Spine Trauma.pptx hgfhjddxxddghhuhbfdvhhjbffSpine Trauma.pptx hgfhjddxxddghhuhbfdvhhjbff
Spine Trauma.pptx hgfhjddxxddghhuhbfdvhhjbff
epicsoundever
 
SEADTIVE HYPNOTIC DRUGS PPT 1.pdf hhfvbbh
SEADTIVE HYPNOTIC DRUGS  PPT 1.pdf hhfvbbhSEADTIVE HYPNOTIC DRUGS  PPT 1.pdf hhfvbbh
SEADTIVE HYPNOTIC DRUGS PPT 1.pdf hhfvbbh
epicsoundever
 
Bipolar Mood disorders 1.pptx nbvbnjjhgfvvb
Bipolar Mood disorders 1.pptx nbvbnjjhgfvvbBipolar Mood disorders 1.pptx nbvbnjjhgfvvb
Bipolar Mood disorders 1.pptx nbvbnjjhgfvvb
epicsoundever
 
ganglionblockers n stimulants.pdf hfvgfffvggvvbh
ganglionblockers n stimulants.pdf hfvgfffvggvvbhganglionblockers n stimulants.pdf hfvgfffvggvvbh
ganglionblockers n stimulants.pdf hfvgfffvggvvbh
epicsoundever
 
MENINGITIS.pptx hbhbbhnsdvjjjhhvdssxvhuhhhh
MENINGITIS.pptx hbhbbhnsdvjjjhhvdssxvhuhhhhMENINGITIS.pptx hbhbbhnsdvjjjhhvdssxvhuhhhh
MENINGITIS.pptx hbhbbhnsdvjjjhhvdssxvhuhhhh
epicsoundever
 
headache all.ppt dnsbsbsnnennandndnssndnnsnsnsn
headache all.ppt dnsbsbsnnennandndnssndnnsnsnsnheadache all.ppt dnsbsbsnnennandndnssndnnsnsnsn
headache all.ppt dnsbsbsnnennandndnssndnnsnsnsn
epicsoundever
 
ANTICHOLINERGICS.pdf ggfvbbhjjjfddvhhhbbbbb
ANTICHOLINERGICS.pdf ggfvbbhjjjfddvhhhbbbbbANTICHOLINERGICS.pdf ggfvbbhjjjfddvhhhbbbbb
ANTICHOLINERGICS.pdf ggfvbbhjjjfddvhhhbbbbb
epicsoundever
 
Wahi.pptx bvvbvdfvghdschhccbjydcvhhfvjhrddvhhgg
Wahi.pptx bvvbvdfvghdschhccbjydcvhhfvjhrddvhhggWahi.pptx bvvbvdfvghdschhccbjydcvhhfvjhrddvhhgg
Wahi.pptx bvvbvdfvghdschhccbjydcvhhfvjhrddvhhgg
epicsoundever
 
Introduction psychiatry .pptx dnsnsnsnennansnnsnd
Introduction psychiatry .pptx dnsnsnsnennansnnsndIntroduction psychiatry .pptx dnsnsnsnennansnnsnd
Introduction psychiatry .pptx dnsnsnsnennansnnsnd
epicsoundever
 

More from epicsoundever (20)

Abdomen and Pelvis Clinicals (1).pdfvmvnxcxc
Abdomen and Pelvis Clinicals (1).pdfvmvnxcxcAbdomen and Pelvis Clinicals (1).pdfvmvnxcxc
Abdomen and Pelvis Clinicals (1).pdfvmvnxcxc
 
Bones upper limb.pdf ckvncxkvnxcvnxcknxcknxk
Bones upper limb.pdf ckvncxkvnxcvnxcknxcknxkBones upper limb.pdf ckvncxkvnxcvnxcknxcknxk
Bones upper limb.pdf ckvncxkvnxcvnxcknxcknxk
 
MULTIPLE_SCLEROSIS_ (1).pptx trrhggfrffghhv
MULTIPLE_SCLEROSIS_ (1).pptx trrhggfrffghhvMULTIPLE_SCLEROSIS_ (1).pptx trrhggfrffghhv
MULTIPLE_SCLEROSIS_ (1).pptx trrhggfrffghhv
 
anatomy and physiology of cornea-.pdf gfhh
anatomy and physiology of cornea-.pdf gfhhanatomy and physiology of cornea-.pdf gfhh
anatomy and physiology of cornea-.pdf gfhh
 
Lecture 16 - Dementia.ppt bvvbbnngfcvbhhhh
Lecture 16 - Dementia.ppt bvvbbnngfcvbhhhhLecture 16 - Dementia.ppt bvvbbnngfcvbhhhh
Lecture 16 - Dementia.ppt bvvbbnngfcvbhhhh
 
SEADTIVE HYPNOTIC DRUGS PPT 2.pdf hghhhhhh we
SEADTIVE HYPNOTIC DRUGS  PPT 2.pdf hghhhhhh weSEADTIVE HYPNOTIC DRUGS  PPT 2.pdf hghhhhhh we
SEADTIVE HYPNOTIC DRUGS PPT 2.pdf hghhhhhh we
 
liver injury.pptx jhfvbghhbbnnnnbcdddvhhhhh
liver injury.pptx jhfvbghhbbnnnnbcdddvhhhhhliver injury.pptx jhfvbghhbbnnnnbcdddvhhhhh
liver injury.pptx jhfvbghhbbnnnnbcdddvhhhhh
 
DEMOGRAPHY.ppt hfggghfssxdrhjjjhddfhhjhgv
DEMOGRAPHY.ppt hfggghfssxdrhjjjhddfhhjhgvDEMOGRAPHY.ppt hfggghfssxdrhjjjhddfhhjhgv
DEMOGRAPHY.ppt hfggghfssxdrhjjjhddfhhjhgv
 
LOCAL ANESTHETICS 2024.pdf jdhsjsnsnejsjnsjwns
LOCAL ANESTHETICS 2024.pdf jdhsjsnsnejsjnsjwnsLOCAL ANESTHETICS 2024.pdf jdhsjsnsnejsjnsjwns
LOCAL ANESTHETICS 2024.pdf jdhsjsnsnejsjnsjwns
 
Ataxia.pptx dbdhndjsjsjdkjzjxjdbfbxnzndndnxj
Ataxia.pptx dbdhndjsjsjdkjzjxjdbfbxnzndndnxjAtaxia.pptx dbdhndjsjsjdkjzjxjdbfbxnzndndnxj
Ataxia.pptx dbdhndjsjsjdkjzjxjdbfbxnzndndnxj
 
Liver injury-2.pptx bxjdndannsmxmfmsmmssmzmzm
Liver injury-2.pptx bxjdndannsmxmfmsmmssmzmzmLiver injury-2.pptx bxjdndannsmxmfmsmmssmzmzm
Liver injury-2.pptx bxjdndannsmxmfmsmmssmzmzm
 
Spine Trauma.pptx hgfhjddxxddghhuhbfdvhhjbff
Spine Trauma.pptx hgfhjddxxddghhuhbfdvhhjbffSpine Trauma.pptx hgfhjddxxddghhuhbfdvhhjbff
Spine Trauma.pptx hgfhjddxxddghhuhbfdvhhjbff
 
SEADTIVE HYPNOTIC DRUGS PPT 1.pdf hhfvbbh
SEADTIVE HYPNOTIC DRUGS  PPT 1.pdf hhfvbbhSEADTIVE HYPNOTIC DRUGS  PPT 1.pdf hhfvbbh
SEADTIVE HYPNOTIC DRUGS PPT 1.pdf hhfvbbh
 
Bipolar Mood disorders 1.pptx nbvbnjjhgfvvb
Bipolar Mood disorders 1.pptx nbvbnjjhgfvvbBipolar Mood disorders 1.pptx nbvbnjjhgfvvb
Bipolar Mood disorders 1.pptx nbvbnjjhgfvvb
 
ganglionblockers n stimulants.pdf hfvgfffvggvvbh
ganglionblockers n stimulants.pdf hfvgfffvggvvbhganglionblockers n stimulants.pdf hfvgfffvggvvbh
ganglionblockers n stimulants.pdf hfvgfffvggvvbh
 
MENINGITIS.pptx hbhbbhnsdvjjjhhvdssxvhuhhhh
MENINGITIS.pptx hbhbbhnsdvjjjhhvdssxvhuhhhhMENINGITIS.pptx hbhbbhnsdvjjjhhvdssxvhuhhhh
MENINGITIS.pptx hbhbbhnsdvjjjhhvdssxvhuhhhh
 
headache all.ppt dnsbsbsnnennandndnssndnnsnsnsn
headache all.ppt dnsbsbsnnennandndnssndnnsnsnsnheadache all.ppt dnsbsbsnnennandndnssndnnsnsnsn
headache all.ppt dnsbsbsnnennandndnssndnnsnsnsn
 
ANTICHOLINERGICS.pdf ggfvbbhjjjfddvhhhbbbbb
ANTICHOLINERGICS.pdf ggfvbbhjjjfddvhhhbbbbbANTICHOLINERGICS.pdf ggfvbbhjjjfddvhhhbbbbb
ANTICHOLINERGICS.pdf ggfvbbhjjjfddvhhhbbbbb
 
Wahi.pptx bvvbvdfvghdschhccbjydcvhhfvjhrddvhhgg
Wahi.pptx bvvbvdfvghdschhccbjydcvhhfvjhrddvhhggWahi.pptx bvvbvdfvghdschhccbjydcvhhfvjhrddvhhgg
Wahi.pptx bvvbvdfvghdschhccbjydcvhhfvjhrddvhhgg
 
Introduction psychiatry .pptx dnsnsnsnennansnnsnd
Introduction psychiatry .pptx dnsnsnsnennansnnsndIntroduction psychiatry .pptx dnsnsnsnennansnnsnd
Introduction psychiatry .pptx dnsnsnsnennansnnsnd
 

Recently uploaded

Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPSSpellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
AnaAcapella
 

Recently uploaded (20)

Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptxExploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
 
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPSSpellings Wk 4 and Wk 5 for Grade 4 at CAPS
Spellings Wk 4 and Wk 5 for Grade 4 at CAPS
 
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
 
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
OSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & SystemsOSCM Unit 2_Operations Processes & Systems
OSCM Unit 2_Operations Processes & Systems
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17How to Add New Custom Addons Path in Odoo 17
How to Add New Custom Addons Path in Odoo 17
 
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structure
 
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdfFICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
FICTIONAL SALESMAN/SALESMAN SNSW 2024.pdf
 
Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)Jamworks pilot and AI at Jisc (20/03/2024)
Jamworks pilot and AI at Jisc (20/03/2024)
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
How to Add a Tool Tip to a Field in Odoo 17
How to Add a Tool Tip to a Field in Odoo 17How to Add a Tool Tip to a Field in Odoo 17
How to Add a Tool Tip to a Field in Odoo 17
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
Sensory_Experience_and_Emotional_Resonance_in_Gabriel_Okaras_The_Piano_and_Th...
 

depression 1 (1).pptx dnsjsjxkskskskskjdjdd

  • 2. OBJECTI VES At the end of lecture students should be able to: • Explain Depressive Mood disorders and its various types as given in DSM V classification. • Describe prevalence; etiology; risk factors and D/D of Depressive disorder. • Formulate a management plan of depressive disorder based on BIOPSYCHOSOCIAL MODEL.
  • 3. CASE: A 42-year-old man comes to his outpatient psychiatrist with complaints of a depressed mood, which he states is identical to depressions he has experienced previously. He was diagnosed with major depression for the first time 20 years ago. At that time, he was treated with imipramine, up to 150 mg/d, with good results. During a second episode, which occurred 15 years ago, he was treated with imipramine, and once again his symptoms remitted after 4 to 6 weeks. He denies illicit drug use or any recent traumatic events. The man states that although he is sure he is experiencing another major depression, he would like to avoid imipramine this time because it produced unacceptable side effects such as dry mouth, dry eyes and constipation. •
  • 4. CAS E ➤What is the psychiatric symptoms and sign in this case? ➤ What is the best therapy? ➤ What are the side effects of the proposed therapy?
  • 5. MOOD DISORDER • Previously called “affective disorders.” • The term “mood disorders is preferred today. • “Mood disorders” refers to disturbance in sustained emotional states rather than external expression of the present emotional state’ • A persons emotional state or outlook at particular time or Generalized state of feeling.
  • 6. Different type of Mood • Normal mood: Low mood experienced by healthy people • Grief : • Adjustment : Anxiety and depressive features because of losses Few mood features because of life events within 6 months of event • Depressive disorder
  • 7. Classification of Depressive Disorder • Disruptive Mood Dysregulation Disorder • Major Depressive Disorder • Persistent Depressive Disorder (Dysthymia) • Premenstrual Dysphoric Disorder • Substance/Medication-Induced Depressive Disorder • Depressive Disorder Due to Another Medical Condition • Other Specified Depressive Disorder • Unspecified Depressive Disorder
  • 8. DSM V Diagnostic criteria's A. Five (or more) symptoms for 2-week period and represent a change from previous with impaired functioning; • At least one of the core symptoms is either 1 . 2 . Depressed mood Loss of interest or pleasure. Associated symptoms 3 . 4 . 5 . Significant weight loss when not dieting or weight gain children, consider failure to make expected weight gain.) Insomnia or hypersomnia nearly every day. Psychomotor agitation or retardation nearly every
  • 9. 6. Fatigue or loss of energy nearly every day. 7. Feelings of worthlessness or excessive or inappropriate guilt (which may be delusional) nearly every day (not merely self reproach or guilt about being sick). 8. Diminished ability to think or concentrate, or indecisiveness 9. Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideation without a specific plan, or a suicide attempt or a specific plan for committing suicide. B. The symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning. C . The episode is not attributable to the physiological effects of a substance or to another medical condition.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16. Dysthymic disorder • A depressive disorder less severe than major depressive disorder • Chronic depressive symptoms, which are not severe enough to fit the diagnosis of major depressive episode • Lasted at least 2 years Atypical depression Younger age of onset More frequent, coexisting with panic disorder, substance-related problems, and somatic symptoms features •Mood reactivity (as compared to usual depression’s lack of response to positive events) • Overeating • Oversleeping • Leaden paralysis • Sensitivity to interpersonal rejection
  • 17. Minor Mood Disorder Two-thirds of the psychiatric disorders seen in general practice. The most frequent symptoms are: ● Anxiety and worrying thoughts ● Sadness and depressive thoughts ● Irritability ● Poor concentration ● Insomnia ● Fatigue ● Somatic symptoms ● Excessive concern about bodily function.  Half of patients with minor mood disorder improve within 3 months  ¼ in 6 months.
  • 18. Moderate depressive disorder • In depressive disorders of moderate severity the central features are again low mood, lack of enjoyment, reduced energy, and pessimistic thinking • 2 core features and 3 associated features.
  • 19. Severe depressive disorder • All features occurs with greater intensity • Worthlessness, hopelessness, guilt, ill health OR poverty of thought. • Delusions and hallucinations mood-congruent • A patient with a delusion of impoverishment may wrongly believe that he has lost all his money in a business venture. • A patient with nihilistic delusions may believe that he has no future, or that some part of him has ceased to exist or function (e.g. that his bowels are wholly blocked—sometimes called Cotard’s syndrome). walking corpse syndrome
  • 20. MS E Appearance • The patient’s appearance is often characteristic Psychomotor retardation. • Agitation and feeling of restlessness which may manifest Mood • The low mood, diurnal variation of mood • Anxiety and irritability are frequent. • Lack of interest and loss of enjoyment (anhedonia) • no spontaneously. • No enthusiasm for activities and hobbies that they would normally enjoy, and describe a loss of zest for living and for the pleasure from everyday things.
  • 21. MS E • Depressive thinking • Pessimistic thinking (‘depressive cognitions’). • Thoughts concerned with the present. • Thoughts concerned with the future. • Thoughts concerned with the past. • Depersonalization, obsessional symptoms, • phobias, and conversion symptoms such as loss of function of a limb
  • 22. DIFFERENTIAL DIAGNOSIS • Normal sadness • Grief. • Bipolar disorder. • Anxiety disorder. • Functional physical symptoms. • Schizophrenia. • Dementia. • Substance abuse.
  • 23. Prevalence • Lifetime risk of depressive disorder is around 20% in both developed and developing countries • women than in men: the sex ratio is about 2 to 1. • Primary care (up to 40% of attenders) • More common in urban than rural populations • Depressive disorders cause both direct and indirect costs to health services. • Depression may be undetected, especially when there are accompanying physical symptoms. • Unrecognized depressive disorder may slow recovery and worsen prognosis in physical illness.
  • 25. Genetic causes • Parents, siblings, and children of severely depressed patients have a higher lifetime risk for mood disorder (10– 15%) than the general population (1–2%). • Twin studies of adopted children shows increased risk of developing the disorder in a child who was born to a parent with a history of serious depressive disorder.
  • 26. PREDISPOSING ENVIRONMENTAL FACTORS • Prolonged diversity of difficulties in marriage or at work. • Adverse circumstances seem to prepare the ground for a final acute stressor, which precipitates the disorder. (Example: several young children, poor economic circumstances, and an unsupportive marriage increase vulnerability to depression). • People whoare more vulnerable include: – Lack of confiding relationships – Unemployment
  • 27. PRECIPITATING ENVIRONMENTAL FACTORS • Depressive disorder follow stressful life events. • The effect is substantial; the risk of developing a depressive disorder is increased about six fold in the 6 months after experiencing moderately severe life events
  • 28. Physical conditions as predisposing or precipitating factors • Most physical conditions are non-specific stressors but a few appear to precipitate depressive disorder by direct biological mechanisms. They include: • Influenza and some other viral infections/ other infection(AIDS) • Anemia • Childbirth • Parkinson’s disease. • Metabolic syndromes • Endocrine abnormalities • Heart diseases • Epilepsy • Cancers • Substance abuse • Nutritional deficiencies • Neurological disorders
  • 29. Psychological mediating processes. • Two kinds of complementary mediating processes have • been studied: – psychological and biochemical. 1 Abnormalities of emotional processing 2 Tendency to remember unhappy events more easily than happy ones. 4 Cognitive distortions. 5 Illogical ways of thinking allow the intrusive gloomy thoughts and the unrealistic expectations to persist despite evidence to the contrary.
  • 30. Biochemical mediating processes. 1 2 3 • Strongest evidence is for an abnormality of 5-HT (serotonin) function. • There are three main strands of evidence. Concentrations of the main 5-HT metabolite (5-HIAA) are reduced in the cerebrospinal fluid (CSF) 5-HT concentrations are reduced in the brains of depressed be caused by drugs used to commit suicide or by post-mortem changes. Neuroendocrine functions that involve 5-HT transmission are reduced in depressed patients. 4 Tryptophan (amino acid precursor of 5-HT) depletion via diet can lead to increased depressive mood in people who have recovered. 5 Noradrenergic (NA) function also seems to be reduced in depressive disorders.
  • 31. MEDICAL CAUSES OF DEPRESSION: • Pharmacologic: steroids, methyldopa, cimetidine, reserpine, cyclosporine, amphetamine withdrawal. • Infectious diseases: Influenza, viral hepatitis, IMN, T.B. • Endocrinal: Hypothyroidism, Cushing, Addison's, postpartum, D.M. • Collagen: SLE, rheumatoid. • Neurological: parkinsonism, stroke, multiple sclerosis. • Nutritional: Vit B12, Vit C &D , Folate, Niacin deficiency, hypercalcemia • Neoplastic: Cancer head pancreas, disseminated malignancy
  • 32. Endocrine Abnormalities • Cushing’s syndrome • Addison’s disease • Hyperparathyroidism • hypothyroidism • childbirth/ menopause /premenstrual syndrome • Plasma cortisol is increased in about half of patients with depressive disorder. • Elevation of cortisol can occur after a prolonged life stress may predispose to depression by interfering with brain 5-HT function.
  • 33. Depression: Differences in Women Compared with Men Parameters Differences in women compared with men Lifetime prevalence rate 20 percent (10 percent in men) Age of onset May be earlier Duration of episodes May be longer Course of illness May more often be recurrent Seasonal effect on mood Greater Association with stressful life events More frequent Atypical symptoms of depression (e.g., hypersomnia, hyperphagia Experienced more often Severity of depression May be greater if self-rated by the patient Guilt feelings May be experienced more often
  • 34. Suicidal behavior Suicide attempted more often but much less often successfully Association of anxiety disorders, especially panic and phobic symptoms Greater Association of eating disorders Greater Association of alcoholism and substance use disorder Usually less Association of thyroid disease Greater Association of migraine headaches Greater Association of antisocial, narcissistic and obsessive-compulsive personalities Less Effect of exogenous and endogenous gonadal steroids on mood Greater
  • 35. Prognosis • Two-thirds of those who are depressed never seek treatment and suffer needlessly. • 80%-90% of those who seek treatment for depression can feel better within just a few weeks.
  • 36. Prognosis • 80% of the patients with major depression will experience further episode of depression. • Average length of each episode is 6 months. • 25 years follow up shows that on average patients experience 5 further episodes. • 1/3 patients do not receive full remission.
  • 37. “To acquire knowledge, one must study, but to acquire wisdom one must observe.”
  • 39. Investigatio n • Detection of depression can be improved if the doctor always remembers to ask two simple screening questions: 1 During the last month, have you often been bothered by feelingdown, depressed, or hopeless? 2 During the last month, have you often been bothered by little interest or pleasure in doing things? • Diagnosis depends on thorough history taking and examination of the physical and mental state.
  • 40. Investigatio n Diagnosis ● History ● Mental state ● Relevant physical examination ● Relevant physical investigation ● Informants’ accounts Severity ● Biological symptoms ● Psychotic symptoms ● Suicide risk, risk to others ● Effect on social functioning
  • 41. Aetiology ● Psychological ● Social ● Physical illness ● Drug therapy Social consequences ● Patient’s everyday life ● Partner and family ● Dangers at work Social resources ● Family support ● Housing ● Work
  • 42. Treatment options 1 Make diagnosis and assess severity 2 Assess need for hospital treatment or multidisciplinary team involvement 3 Explain diagnosis, treatment plan, and likely effect of treatment (benefits and harms) to patient and relatives 4 Review after 7 days , Assess side effects, provide explanation and reassurance and Monitor every 7–14 days 5 Assess response to treatment by 6 weeks If better: Continue treatment ,Review need to
  • 43. Classification of Medication • SSRI fluoxetine paroxetin e sertralin e citalopram and escitalopram • SNRI – Venlaflexine – Duloxieten • TRICYCLIC – Imipramine – Amitriptyline – Dothiapine – clomipramine • MAOI
  • 44. Indications for SSRI treatment for depressive disorder • Concomitant cardiac disease • Intolerance to anticholinergic side effects • Significant risk of deliberate overdose • Excessive weight gain with previous tricyclic treatment • Sedation undesirable • Obsessive-compulsive disorder with depression
  • 45. Side effects of SSRI • Gastrointestinal Nausea • Flatulence • Diarrhea • Insomnia • Restlessness • Irritability • Agitation • Tremor • Headache • Acute dystonia, rarely • Erectile andEjaculatory delay
  • 46. Tricyclic antidepressants • Toxic effects on the cardiovascular system. • Tricyclic's have been replaced for most purposes by SSRIs. • Proven effectiveness in severely depressed patients. Contraindications • Agranulocytosis • Liver damage • Glaucoma • Prostatic hypertrophy • Used cautiously in epileptic patients.
  • 47. Side effects of Tricyclic Antidepressants Anticholinergic effects : • Dry mouth, Constipation, Impaired visual accommodation • Difficulty in micturition, Worsening of glaucoma, Confusion (especially in the elderly) Alpha- adenoreceptor blocking effects • Drowsiness • Postural hypotension • Sexual dysfunction Cardiovascular effects • Tachycardia • Hypotension • Cardiac conduction deficits • Cardiac arrhythmia Other effects Seizures Weight gain
  • 48. Psychological Treatment • Support, encouragement, and repeated explanation that they are suffering from illness, not moral failure. • When the depressive disorder appears to have been precipitated by life problems, discussion and problem- solving counselling may be required. • CBT • When the depressive disorder is severe, discussion of problems may increase hopelessness. • When mood improves, the problems can be reconsidered.
  • 49. Social Intervention • Family support • Family education and involvement in care • Financial support • Relaxation in work
  • 50. Indications for ECT 1 The need for an urgent response: (i) when life is threatened in a severe depressive disorder • Refusal to drink or eat • Intense suicidal ideation (ii) Puerperal psychiatric disorders when it is important that the mother should resume the care of her baby 2 3 Resistant depressive disorder Failure to thorough treatment with antidepressant medication. Two uncommon syndromes (i) Catatonic schizophrenia (ii) Depressive stupor
  • 51. THE ANSWER OF THE CASE (1) • • Summary: A 42-year-old man complains of symptoms of major depression identical to two prior episodes he experienced in the past. Previously, he was successfully treated with a tricyclic antidepressant (TCA), although this class of medication often produces anticholinergic side effects such as dry mouth, dry eyes, and constipation, of which this patient complains. The question becomes what medication should be used to treat recurrent major depression when tricyclics are not an option. •
  • 52. Best therapy: • A selective serotonin reuptake inhibitor (SSRI) such as sertraline, paroxetine, citalopram, fluoxetine, or fluvoxamine is one of the first-line choices of medication for this patient. • Selective serotonin norepinephrine reuptakeinhibitors (SSNRI) such as venlafaxine and duloxetine are also first-line treatment options.